Who owns GRACELL BIOTECHNOLOGIES INC?
- CUSIP Number: 38406l103
Tip: Access positions for across all investors
Analyze quarterly positions in Gracell Biotechnologies with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Gracell Biotechnologies stock
Who bought or sold GRACELL BIOTECHNOLOGIES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vivo Capital | 9.5M | $96M | -12% | Dec 2023 |
|
| OrbiMed Advisors | 9.3M | $94M | 0% | Dec 2023 |
|
| Tang Capital Management | 2.2M | $22M | 1277% | Dec 2023 |
|
| Baker Bros. Advisors | 2.1M | $21M | 108% | Dec 2023 |
|
| Pentwater Capital Management | 1.5M | $15M | 100% | Dec 2023 |
|
| TIG Advisors | 1.3M | $13M | 100% | Dec 2023 |
|
| Alpine Associates Management | 1.3M | $13M | 100% | Dec 2023 |
|
| Octagon Capital Advisors | 597k | $6.0M | 100% | Dec 2023 |
|
| Bank of America Corporation | 512k | $5.1M | 76885% | Dec 2023 |
|
| LMR Partners | 510k | $3.3M | 5% | Dec 2023 |
|
| Sphera Funds Management | 503k | $5.0M | -67% | Dec 2023 |
|
| MMCAP International Inc. SPC | 451k | $4.5M | 100% | Dec 2023 |
|
| Hudson Bay Capital Management | 267k | $2.7M | -87% | Dec 2023 |
|
| Marshall Wace | 193k | $1.9M | 61% | Dec 2023 |
|
| Millennium Management | 191k | $1.9M | 1106% | Dec 2023 |
|
| CNH Partners | 131k | $1.3M | 100% | Dec 2023 |
|
| UBS Group | 126k | $1.3M | 5336% | Dec 2023 |
|
| Weiss Asset Management LP[1 | 109k | $1.1M | 100% | Dec 2023 |
|
| Two Sigma Investments | 88k | $880k | 167% | Dec 2023 |
|
| CSS | 73k | $733k | 100% | Dec 2023 |
|
| Citadel Advisors | 65k | $652k | 100% | Dec 2023 |
|
| Cubist Systematic Strategies | 59k | $593k | 4098% | Dec 2023 |
|
| Fifth Lane Capital | 58k | $586k | 100% | Dec 2023 |
|
| Polar Securities | 50k | $502k | 100% | Dec 2023 |
|
| Pathstone Holdings | 49k | $494k | 100% | Dec 2023 |
|
| Exome Asset Management | 41k | $411k | 100% | Dec 2023 |
|
| Two Sigma Advisers | 34k | $337k | 100% | Dec 2023 |
|
| Equitec Proprietary Markets | 32k | $323k | 100% | Dec 2023 |
|
| Gts Securities | 25k | $252k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 25k | $251k | 83333% | Dec 2023 |
|
| PenderFund Capital Management | 23k | $300k | 100% | Dec 2023 |
|
| Balyasny Asset Management | 20k | $203k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 18k | $182k | 13% | Dec 2023 |
|
| Jpmorgan Chase & Co | 14k | $141k | 9% | Dec 2023 |
|
| Virtu Financial | 11k | $109k | 100% | Dec 2023 |
|
| Barclays | 11k | $106k | -97% | Dec 2023 |
|
| FNY Investment Advisers | 10k | $100k | 100% | Dec 2023 |
|
| China Universal Asset Management | 8.4k | $84k | 381% | Dec 2023 |
|
| Wells Fargo & Company | 7.2k | $72k | 7% | Dec 2023 |
|
| Simplex Trading | 1.6k | $16k | 100% | Dec 2023 |
|
| Citigroup | 1.3k | $13k | 56% | Dec 2023 |
|
| Eagle Bay Advisors | 210.00 | $2.1k | 0% | Dec 2023 |
|
| Pnc Financial Services | 150.00 | $1.5k | 0% | Dec 2023 |
|
| Daiwa Securities Group | 146.00 | $999.997800 | 0% | Dec 2023 |
|
Who sold out of Gracell Biotechnologies?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Logos Global Management | Sep 2023 | 2.5M | $7.3M |
| Schonfeld Strategic Advisors | Sep 2023 | 759k | $2.2M |
| Dr. Jeffrey R. Jay, M.D. | Sep 2023 | 580k | $1.7M |
| DeepCurrents Investment Group | Sep 2023 | 275k | $792k |
| Fred Alger Management | Sep 2023 | 62k | $177k |
| Bellevue Group | Sep 2023 | 38k | $109k |
| Point72 Asset Management | Sep 2023 | 31k | $90k |